Correction|Volume 12, Issue 7|pp 6486—6487

Correction for: Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance

Lan Ye^1,², Anne L. Widlund^2,³, Carrie A. Sims^2,⁴, Dudley W. Lamming⁵, Yuxia Guan⁴, James G. Davis², David M. Sabatini⁵, David E. Harrison, Ole Vang³, Joseph A. Baur²

¹State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China
²Institute for Diabetes, Obesity, and Metabolism and Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
³Department of Science, Systems and Models, Roskilde University, Roskilde, Denmark
⁴Division of Trauma, Critical Care, and Emergency Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA
⁵Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology, Department of Biology, Cambridge, MA 02142, USA
⁶The Jackson Laboratory, Bar Harbor, ME 04609, USA

Received: February 4, 2020Accepted: March 15, 2020Published: April 8, 2020

https://doi.org/10.18632/aging.102976

Copyright © 2020 Ye et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: The authors requested the replacement of Figure 3B. They discovered that a residual band from incomplete stripping was inadvertently presented in place of the GAPDH band. The authors revised Figure 3B.

This correction does not change the content of the publication and does not affect the conclusion of this research.

The corrected Figure 3 is provided below.

Figure 3.

Rapamycin does not change mitochondrial protein expression in Het3 mice from invention testing program. Mitochondrial oxidative phosphorylation complexes were measured in (A) young (6-month-old) or (B) old (21-month-old) HET3 mice treated with rapamycin-containing diet for 2 months or 5 months. Antibodies as described for Figure 2.